N-11-Phenylundecanoyl-L-homoserine Lactone

ID: ALA447291

PubChem CID: 25258813

Max Phase: Preclinical

Molecular Formula: C21H31NO3

Molecular Weight: 345.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCCCCCCCCCc1ccccc1)N[C@H]1CCOC1=O

Standard InChI:  InChI=1S/C21H31NO3/c23-20(22-19-16-17-25-21(19)24)15-11-6-4-2-1-3-5-8-12-18-13-9-7-10-14-18/h7,9-10,13-14,19H,1-6,8,11-12,15-17H2,(H,22,23)/t19-/m0/s1

Standard InChI Key:  OVBODEHQKJBHAL-IBGZPJMESA-N

Molfile:  

     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
   29.5539  -14.7303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7539  -14.9428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7088  -15.7693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4809  -16.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0032  -15.4255    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6928  -16.8650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9917  -16.1750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2808  -15.7562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2881  -14.9313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5628  -16.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8520  -15.7437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1339  -16.1499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4231  -15.7312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7050  -16.1374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9942  -15.7186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2822  -16.1248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5699  -15.7087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8533  -16.1175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1409  -15.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4244  -16.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7138  -15.6926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9977  -16.1008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9931  -16.9267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7104  -17.3427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4236  -16.9321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  6  2  0
 12 13  1  0
 13 14  1  0
  3  7  1  1
 14 15  1  0
  2  3  1  0
 15 16  1  0
  7  8  1  0
 16 17  1  0
  3  4  1  0
 17 18  1  0
  8  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  5  1  1  0
 21 22  1  0
 10 11  1  0
 22 23  2  0
  1  2  1  0
 23 24  1  0
 11 12  1  0
 24 25  2  0
 25 20  1  0
M  END

Alternative Forms

Associated Targets(Human)

NCI-H630 (194 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 345.48Molecular Weight (Monoisotopic): 345.2304AlogP: 4.17#Rotatable Bonds: 12
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.61CX Basic pKa: CX LogP: 4.75CX LogD: 4.75
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.46Np Likeness Score: -0.15

References

1. Oliver CM, Schaefer AL, Greenberg EP, Sufrin JR..  (2009)  Microwave synthesis and evaluation of phenacylhomoserine lactones as anticancer compounds that minimally activate quorum sensing pathways in Pseudomonas aeruginosa.,  52  (6): [PMID:19260689] [10.1021/jm8015377]

Source